Problem:
Many clinical genetic and genomic labs knowingly or unknowingly take inappropriate shortcuts that may ultimately lead to mistakes in their test validations. These ‘mistakes’ can impact patient care and outcomes. With LDTs not being regulated, they can go to market without an independent analysis to validate claims of the seller (the lab).
Solution:
Until the VALID Act passes so that the FDA has oversight of Laboratory Developed Tests (LDTs) or CLIA and CAP Accreditation includes analysis of variant classification and accuracy evaluations, then an unbiased, third party evaluation is essential to ensure that reports delivered to physicians and their patients is ACCURATE!
CGI is here to ensure your patients are getting accurate results!
The nonprofit Center for Genomic Interpretation (CGI) can assist by taking a non-biased approach by reviewing testing options to ensure the tests are being accurately represented. When choosing a genetic testing lab, ensure you are ordering or choosing a lab for ‘in network’ status that is delivering accurate results! Let us analyze this quickly and inexpensively today! Our review of a lab test’s technical accuracy costs less than a single risk reducing surgery or precision medicine therapy option.
Please email truth-in-genomics@genomicinterpretation.org to sign up for monthly newsletters and follow Center For Genomic Interpretation on LinkedIn to keep up with this ever changing industry!
View newsletter HERE!